Submission of a manuscript to npj Precision Oncology implies that all authors have read and approved their content and that the manuscript conforms to our editorial policies. Authorship provides ...
JCO is the primary forum of scientific discourse for the American Society of Clinical Oncology (ASCO). Published three times a month, JCO is the foremost peer-reviewed journal focusing on clinical ...
Mural Oncology's stock plummeted 57% after halting the Phase 3 ARTISTRY-7 trial for nemvaleukin alfa. Click here to read an ...
The corresponding author should indicate whether the work described in the manuscript has been discussed with a specific Editor at npj Precision Oncology before submission. Copies of any papers ...
The authors have previously documented population-level need ... It merits its chance to earn full interventional standing in modern multidisciplinary oncology.
Hayden E. Klein,Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC Jorge García, PharmD, MS, MBA, MHA, highlights the need for infusion pharmacy optimization to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results